Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Turning Point Therapeutics, Inc. TPTX

Full chart Compare
Set alert

Price alert · TPTX

All alert types
75.49 +75.49

Day range unavailable

52-week range unavailable

Valuation

P/E -8.2×
FY 2017: -26.0×FY 2018: -17.4×FY 2019: -20.8×FY 2020: -31.6×FY 2021: -8.2×
FY 2017 5y median -20.8× FY 2021
P/S 63.2×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 199×FY 2021: 63.2×
FY 2017 5y median 0.0× FY 2021
P/B 2.0×
FY 2017: -17.4×FY 2018: 4.4×FY 2019: 3.7×FY 2020: 4.5×FY 2021: 2.0×
FY 2017 5y median 3.7× FY 2021
P/FCF -12.5×
FY 2017: -33.9×FY 2018: -18.1×FY 2019: -25.3×FY 2020: -59.2×FY 2021: -12.5×
FY 2017 5y median -25.3× FY 2021
EV/EBITDA -6.6×
FY 2017: -23.4×FY 2018: -13.4×FY 2019: -20.7×FY 2020: -28.6×FY 2021: -6.6×
FY 2017 5y median -20.7× FY 2021
EV/Sales 49.5×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 177×FY 2021: 49.5×
FY 2017 5y median 0.0× FY 2021
FCF Yield -8.0%
FY 2017: -2.9%FY 2018: -5.5%FY 2019: -4.0%FY 2020: -1.7%FY 2021: -8.0%
FY 2017 5y median -4.0% FY 2021

Profitability

Gross Margin 100.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 100.0%
FY 2017 5y median 0.0% FY 2021
Operating Margin -767.3%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -647.3%FY 2021: -767.3%
FY 2017 5y median 0.0% FY 2021
Net Margin -767.3%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -629.2%FY 2021: -767.3%
FY 2017 5y median 0.0% FY 2021
ROE -24.8%
FY 2017: 66.8%FY 2018: -25.4%FY 2019: -17.8%FY 2020: -14.2%FY 2021: -24.8%
FY 2017 5y median -17.8% FY 2021
ROIC -24.6%
FY 2017: -40.4%FY 2018: -26.2%FY 2019: -19.0%FY 2020: -14.5%FY 2021: -24.6%
FY 2017 5y median -24.6% FY 2021
ROA -23.6%
FY 2017: -36.1%FY 2018: -24.0%FY 2019: -17.1%FY 2020: -13.8%FY 2021: -23.6%
FY 2017 5y median -23.6% FY 2021

Growth (YoY)

Revenue 23.3%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 23.3%
FY 2017 FY 2021
Operating Income -46.2%
FY 2017: 0.0%FY 2018: -53.3%FY 2019: -203.1%FY 2020: -108.2%FY 2021: -46.2%
FY 2017 FY 2021
EPS (diluted) -50.4%
FY 2017: 0.0%FY 2018: -49.5%FY 2019: -80.1%FY 2020: -28.8%FY 2021: -50.4%
FY 2017 FY 2021
Free Cash Flow -86.0%
FY 2017: 0.0%FY 2018: -87.3%FY 2019: -149.6%FY 2020: -41.3%FY 2021: -86.0%
FY 2017 FY 2021

Financial Health

Current Ratio 21.1×
FY 2017: 10.1×FY 2018: 19.1×FY 2019: 29.6×FY 2020: 46.4×FY 2021: 21.1×
FY 2017 5y median 21.1× FY 2021
Quick Ratio 21.1×
FY 2017: 10.1×FY 2018: 19.1×FY 2019: 29.6×FY 2020: 46.4×FY 2021: 21.1×
FY 2017 5y median 21.1× FY 2021
Debt / Equity 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×
FY 2017 5y median 0.0× FY 2021
Net Debt / EBITDA 1.8×
FY 2017: 2.7×FY 2018: 4.1×FY 2019: 0.6×FY 2020: 3.6×FY 2021: 1.8×
FY 2017 5y median 2.7× FY 2021
Interest Coverage 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×
FY 2017 5y median 0.0× FY 2021

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2017 5y median 0.0% FY 2021
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2017 5y median 0.0% FY 2021

Annual · latest fiscal year ends 2021-12-31